Amgen (AMGN) Tops Q3 Earnings and Revenue Estimates

What happened: Amgen (AMGN) reported quarterly adjusted earnings of $6.45 per share and revenue of $10.37 billion, beating Zacks consensus estimates for both. Key numbers: EPS $6.45 vs. $5.74 estimate; earnings surprise +12.37%; revenue $10.37 billion vs. Why it matters: Amgen has topped consensus EPS and revenue estimates in each of the last four quarters. The article says the stock's near-term move will depend mostly on management commentary on the earnings call and on estimate revisions, with the current Zacks Rank pointing to market-like performance. Market: -0.9% today ($461.26), +42.8% YTD, 0.8x vol — as of 00:45 UTC Verified: Q3_2026 (Nov 3) EPS $6.45 vs $5.78 est, +11.5% beat; next print ~Feb 2 Coverage: 8 outlets in 24h

Amgen (AMGN) reported quarterly adjusted earnings of $6.45 per share and revenue of $10.37 billion, beating Zacks consensus estimates for both.

Amgen has topped consensus EPS and revenue estimates in each of the last four quarters. The article says the stock's near-term move will depend mostly on management commentary on the earnings call and on estimate revisions, with the current Zacks Rank pointing to market-like performance. Market: -0.9% today ($461.26), +42.8% YTD, 0.8x vol — as of 00:45 UTC Verified: Q3_2026 (Nov 3) EPS $6.45 vs $5.78 est, +11.5% beat; next print ~Feb 2